Regulated analytics Prozess Technologie specialized in in-line spectroscopy systems that are fully compliant with FDA 21 CFR Part 11, PAT, cGMP, and pharmacopeia standards, indicating strong potential for selling to regulated pharmaceutical and biotech manufacturers seeking compliant real-time process analytics.

Real-time value The company offers closed-loop, in-line spectroscopy capable of continuous, real-time measurement on production lines, presenting a compelling pitch to manufacturers aiming to improve product quality, increase yield, and reduce waste through process analytics.

Diverse markets Deployments across Pharmaceuticals, Life Sciences, Food & Beverage, Agriculture, and Petrochemicals suggest cross-industry applicability; opportunities may exist in adjacent sectors needing real-time monitoring and quality control.

NIR to FLD Product portfolio combines hardware like NIR, UV-Vis, and Light-Induced Fluorescence with software solutions (NovaPAC and NovaMath), indicating potential upsell to customers requiring integrated hardware-software analytics platforms and chemometrics.

Growth opportunities With revenue in the low to mid millions and a small team, there may be channels for partnerships, advisory engagements, or spin-out ventures that leverage their regulatory, analytical, and process-engineering expertise to scale new process analytics solutions.